These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26986027)

  • 21. [IMRT combined to IGRT: increase of the irradiated volume. Consequences?].
    Lisbona A; Averbeck D; Supiot S; Delpon G; Ali D; Vinas F; Diana C; Murariu C; Lagrange JL
    Cancer Radiother; 2010 Oct; 14(6-7):563-70. PubMed ID: 20729117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].
    Teh BS; Paulino A; Butler EB
    Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
    Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
    Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Perspectives in biological modulation of radiotherapy].
    Deutsch E; Huguet F
    Bull Cancer; 2005 Jan; 92(1):90-6. PubMed ID: 16123013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Communication of benefits and risks of medical radiation: a historical perspective.
    Timins JK
    Health Phys; 2011 Nov; 101(5):562-5. PubMed ID: 21979541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Special groups: head and neck cancer.
    Arrese LC; Lazarus CL
    Otolaryngol Clin North Am; 2013 Dec; 46(6):1123-36. PubMed ID: 24262964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of three dimensional conformal radiation therapy: prospects, opportunities, and challenges.
    Vijayakumar S; Chen GT
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):979-83. PubMed ID: 7493859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial design and scoring of radionuclide therapy endpoints: normal organ toxicity and tumor response.
    Meredith R
    Cancer Biother Radiopharm; 2002 Feb; 17(1):83-99. PubMed ID: 11915176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical models and simpler dosimetric descriptors of radiation late toxicity.
    Kong FM; Pan C; Eisbruch A; Ten Haken RK
    Semin Radiat Oncol; 2007 Apr; 17(2):108-20. PubMed ID: 17395041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some cases of severe normal tissue toxicity can be anticipated with ablated fractionated radiation with appropriate long-term follow-up.
    Dolinsky C; Glatstein E
    Semin Radiat Oncol; 2008 Oct; 18(4):229-33. PubMed ID: 18725108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation biology: the conceptual and practical impact on radiation therapy.
    Suit HD
    Radiat Res; 1983 Apr; 94(1):10-40. PubMed ID: 6344129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological effects of low level exposures to ionizing radiation: theory and practice.
    Liu SZ
    Hum Exp Toxicol; 2010 Apr; 29(4):275-81. PubMed ID: 20332172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of radiation-induced normal tissue complications in radiotherapy using functional image data.
    Nioutsikou E; Partridge M; Bedford JL; Webb S
    Phys Med Biol; 2005 Mar; 50(6):1035-46. PubMed ID: 15798307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal tissue tolerance dose metrics for radiation therapy of major organs.
    Milano MT; Constine LS; Okunieff P
    Semin Radiat Oncol; 2007 Apr; 17(2):131-40. PubMed ID: 17395043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction to clinical radiation biology.
    Willers H; Held KD
    Hematol Oncol Clin North Am; 2006 Feb; 20(1):1-24. PubMed ID: 16580554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience.
    Desai NB; Stein NF; LaQuaglia MP; Alektiar KM; Kushner BH; Modak S; Magnan HM; Goodman K; Wolden SL
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e67-72. PubMed ID: 23084475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Saving normal tissues - a goal for the ages.
    Groves AM; Williams JP
    Int J Radiat Biol; 2019 Jul; 95(7):920-935. PubMed ID: 30822213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions.
    Bentzen SM; Harari PM; Bernier J
    Nat Clin Pract Oncol; 2007 Mar; 4(3):172-80. PubMed ID: 17327857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.